
Nicole Erin Kinsey White
Examiner (ID: 18489, Phone: (571)272-9943 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1671, 1672, 1648 |
| Total Applications | 1130 |
| Issued Applications | 560 |
| Pending Applications | 136 |
| Abandoned Applications | 472 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11561936
[patent_doc_number] => 09624510
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-18
[patent_title] => 'Adenoviral vectors comprising partial deletions of E3'
[patent_app_type] => utility
[patent_app_number] => 14/190787
[patent_app_country] => US
[patent_app_date] => 2014-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1943
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14190787
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/190787 | Adenoviral vectors comprising partial deletions of E3 | Feb 25, 2014 | Issued |
Array
(
[id] => 10729854
[patent_doc_number] => 20160076003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'NOVEL BACTERIOPHAGE AND ANTIBACTERIAL COMPOSITION COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/767266
[patent_app_country] => US
[patent_app_date] => 2014-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7580
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14767266
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/767266 | Bacteriophage and antibacterial composition comprising the same | Feb 25, 2014 | Issued |
Array
(
[id] => 9545418
[patent_doc_number] => 20140170065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-19
[patent_title] => 'Methods and Compositions for Treatment of Human Immunodeficiency Virus Infection with Conjugated Antibodies or Antibody Fragments'
[patent_app_type] => utility
[patent_app_number] => 14/187549
[patent_app_country] => US
[patent_app_date] => 2014-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20914
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14187549
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/187549 | Methods and Compositions for Treatment of Human Immunodeficiency Virus Infection with Conjugated Antibodies or Antibody Fragments | Feb 23, 2014 | Abandoned |
Array
(
[id] => 9670495
[patent_doc_number] => 20140234357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'H5 PROTEINS OF H5N1 INFLUENZA VIRUS FOR USE AS A MEDICAMENT'
[patent_app_type] => utility
[patent_app_number] => 14/184919
[patent_app_country] => US
[patent_app_date] => 2014-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33719
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14184919
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/184919 | H5 PROTEINS OF H5N1 INFLUENZA VIRUS FOR USE AS A MEDICAMENT | Feb 19, 2014 | Abandoned |
Array
(
[id] => 9756198
[patent_doc_number] => 20140286900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => '2\'-BRANCHED NUCLEOSIDES AND FLAVIVIRIDAE MUTATION'
[patent_app_type] => utility
[patent_app_number] => 14/183438
[patent_app_country] => US
[patent_app_date] => 2014-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 45360
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14183438
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/183438 | 2'-BRANCHED NUCLEOSIDES AND FLAVIVIRIDAE MUTATION | Feb 17, 2014 | Abandoned |
Array
(
[id] => 12387786
[patent_doc_number] => 09963501
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-08
[patent_title] => B cell lineage based immunogen design with humanized animals
[patent_app_type] => utility
[patent_app_number] => 14/174563
[patent_app_country] => US
[patent_app_date] => 2014-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10459
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 403
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14174563
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/174563 | B cell lineage based immunogen design with humanized animals | Feb 5, 2014 | Issued |
Array
(
[id] => 9602578
[patent_doc_number] => 20140199260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-17
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF HIV'
[patent_app_type] => utility
[patent_app_number] => 14/167372
[patent_app_country] => US
[patent_app_date] => 2014-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 7363
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14167372
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/167372 | Compositions comprising a Brd4 antagonist and methods for the treatment of HIV | Jan 28, 2014 | Issued |
Array
(
[id] => 11828754
[patent_doc_number] => 09725486
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-08
[patent_title] => 'Methods of treating HIV diseases using novel expression vectors'
[patent_app_type] => utility
[patent_app_number] => 14/153576
[patent_app_country] => US
[patent_app_date] => 2014-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 100
[patent_figures_cnt] => 104
[patent_no_of_words] => 31221
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14153576
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/153576 | Methods of treating HIV diseases using novel expression vectors | Jan 12, 2014 | Issued |
Array
(
[id] => 9596769
[patent_doc_number] => 20140193449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-10
[patent_title] => 'COMPOSITIONS AND METHODS FOR CANCER TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 14/149911
[patent_app_country] => US
[patent_app_date] => 2014-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 33677
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14149911
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/149911 | COMPOSITIONS AND METHODS FOR CANCER TREATMENT | Jan 7, 2014 | Abandoned |
Array
(
[id] => 10938919
[patent_doc_number] => 20140341941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-20
[patent_title] => 'VACCINES AND METHODS FOR USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/139729
[patent_app_country] => US
[patent_app_date] => 2013-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 35576
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14139729
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/139729 | HIV consensus envelope sequences and methods for using the same | Dec 22, 2013 | Issued |
Array
(
[id] => 9568671
[patent_doc_number] => 20140186384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'VACCINES AND METHODS FOR USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/139660
[patent_app_country] => US
[patent_app_date] => 2013-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 35575
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14139660
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/139660 | hTERT sequences and methods for using the same | Dec 22, 2013 | Issued |
Array
(
[id] => 12490053
[patent_doc_number] => 09994629
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Compositions and methods for generating a synthetic antibody
[patent_app_type] => utility
[patent_app_number] => 14/651740
[patent_app_country] => US
[patent_app_date] => 2013-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 67
[patent_no_of_words] => 29615
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14651740
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/651740 | Compositions and methods for generating a synthetic antibody | Dec 12, 2013 | Issued |
Array
(
[id] => 9615716
[patent_doc_number] => 20140205573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-24
[patent_title] => 'ONCOLYTIC VIROTHERAPY FOR THE THERAPY OF SARCOMA'
[patent_app_type] => utility
[patent_app_number] => 14/105599
[patent_app_country] => US
[patent_app_date] => 2013-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6715
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14105599
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/105599 | Oncolytic virotherapy for the therapy of ewing'S sarcoma | Dec 12, 2013 | Issued |
Array
(
[id] => 10635663
[patent_doc_number] => 09353157
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-31
[patent_title] => 'Influenza inhibiting compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 14/101452
[patent_app_country] => US
[patent_app_date] => 2013-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 12184
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14101452
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/101452 | Influenza inhibiting compositions and methods | Dec 9, 2013 | Issued |
Array
(
[id] => 9560708
[patent_doc_number] => 20140178421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'Use of Native Peptides and Their Optimized Derivatives For Vaccination'
[patent_app_type] => utility
[patent_app_number] => 14/099881
[patent_app_country] => US
[patent_app_date] => 2013-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9070
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14099881
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/099881 | Use of Native Peptides and Their Optimized Derivatives For Vaccination | Dec 5, 2013 | Abandoned |
Array
(
[id] => 11763015
[patent_doc_number] => 09371373
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-21
[patent_title] => 'Monomeric VHH domain derived from anti-VP6 camelid antibodies, dimeric domain, immunisation method, composition, and treatment methods for rotavirus infections'
[patent_app_type] => utility
[patent_app_number] => 14/095365
[patent_app_country] => US
[patent_app_date] => 2013-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 8
[patent_no_of_words] => 10219
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14095365
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/095365 | Monomeric VHH domain derived from anti-VP6 camelid antibodies, dimeric domain, immunisation method, composition, and treatment methods for rotavirus infections | Dec 2, 2013 | Issued |
Array
(
[id] => 9757289
[patent_doc_number] => 20140287990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'COMPOSITIONS AND METHODS TO CONCURRENTLY TREAT AND/OR PREVENT MULTIPLE DISEASES WITH CUPREDOXINS'
[patent_app_type] => utility
[patent_app_number] => 14/093558
[patent_app_country] => US
[patent_app_date] => 2013-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 74
[patent_figures_cnt] => 74
[patent_no_of_words] => 52048
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14093558
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/093558 | COMPOSITIONS AND METHODS TO CONCURRENTLY TREAT AND/OR PREVENT MULTIPLE DISEASES WITH CUPREDOXINS | Dec 1, 2013 | Abandoned |
Array
(
[id] => 12037851
[patent_doc_number] => 09816072
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-14
[patent_title] => 'Method for obtaining antigen-specific human antibodies by in vitro immunisation'
[patent_app_type] => utility
[patent_app_number] => 14/647151
[patent_app_country] => US
[patent_app_date] => 2013-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 17548
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14647151
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/647151 | Method for obtaining antigen-specific human antibodies by in vitro immunisation | Nov 25, 2013 | Issued |
Array
(
[id] => 9491002
[patent_doc_number] => 20140141408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'INTEGRATED SENSOR FOR THE RAPID IDENTIFICATION OF BACTERIA USING ISFETS'
[patent_app_type] => utility
[patent_app_number] => 14/088323
[patent_app_country] => US
[patent_app_date] => 2013-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6658
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14088323
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/088323 | INTEGRATED SENSOR FOR THE RAPID IDENTIFICATION OF BACTERIA USING ISFETS | Nov 21, 2013 | Abandoned |
Array
(
[id] => 9596801
[patent_doc_number] => 20140193481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-10
[patent_title] => 'STABILISED VACCINE COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/086038
[patent_app_country] => US
[patent_app_date] => 2013-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16271
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14086038
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/086038 | STABILISED VACCINE COMPOSITION | Nov 20, 2013 | Abandoned |